Drugs / valtorcitabine
valtorcitabine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00128544 | May 2005 → May 2007 | hepatitis B virus infection | Novartis | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | valtorcitabine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00128544 ↗ |
| Known as | 3'-val-l-dc | ChEMBL registry synonym — accepted as the source's own label CHEMBL2106499 ↗ |
| Known as | NM-147 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2106499 ↗ |
| Known as | Valtorcitabina | ChEMBL registry synonym — accepted as the source's own label CHEMBL2106499 ↗ |
| Known as | VALTORCITABINE DIHYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL2106499 ↗ |
| Modality | Small molecule | — CHEMBL2106499 ↗ |